Krakow, Poland – May 19, 2022 – Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, today announced that the Company will participate in the following upcoming investors’ conferences:
UBS Global Healthcare Conference
Format: Corporate overview presentation and one-on-one investor meetings
Date: Monday, May 23rd, 2022, in New York, NY
Presentation Time: 11:30 AM EST
H.C. Wainwright Global Investment Conference
Format: Corporate overview presentation and one-on-one investor meetings
Date: Wednesday, May 25th, 2022, in Miami, FL
Presentation Time: 4:30 PM EST
Erste CEE Technology & Innovation Conference
Format: One-on-one, and group investor meetings
Date: Wednesday, May 25th, 2022, Virtual
IPOPEMA CEE Days
Format: Group investor meeting and Q&A session
Date: Wednesday, June 1st, 2022, Warsaw, Poland
Meeting Time: 2 PM CEST
Pekao Technology Conference
Format: One-on-one investor meetings
Date: Wednesday, June 8th, 2022, Virtual
During the UBS 2022 Global Healthcare Conference and the 2022 H.C. Wainwright Global Investment Conferences, Vatnak Vat-Ho, Chief Business Officer of Ryvu Therapeutics will give a corporate overview and participate in investor meetings. The presentations will be available to conference registrants on-demand. Broader Ryvu management team will be available for meetings during Erste, Ipopema, and Pekao conferences.